USPTO serial 90709359
COVAX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- GARDNER, DAWNA BERYL
- Law office
- LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with COVAX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Pam Kohli Jacobson
Pam Kohli Jacobson K&L GATES LLP925 4TH AVE. STE. 2900SEATTLE, WA 98104-1158United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Advertising services, namely, promoting public awareness of public health, the benefits of vaccines for preventing and treating SARS-COV2, COVID-19, and coronavirus diseases and disorders, the risks of not getting vaccinated to prevent and treat SARS-COV2, COVID-19, and coronavirus diseases and disorders, the health risks of an under-immunized community, and equitable access to vaccines for preventing and treating SARS-COV2, COVID-19, and coronavirus diseases and disorders all the foregoing by means of public advocacy; procurement services for others, namely, purchasing vaccines for preventing and treating SARS-COV2, COVID-19, and coronavirus diseases and disorders | ACTIVE | Jun 4, 2020 |
| 036 | Charitable fund-raising services by means of organizing and conducting fundraising events to promote donations for the purchase and supply of medical goods and services; Financial services, namely, investment of funds for the research, development, manufacture and distribution of vaccines for preventing and treating SARS-COV2, COVID-19, and coronavirus diseases and disorders; insurance services, namely, providing no-fault claim compensation; insurance authorization support, namely, insurance claims processing and providing insurance information | ACTIVE | Jun 4, 2020 |
| 041 | Providing on-line articles, publication of texts and journals and digital video publishing services all in the fields of public health, the benefits of vaccines for preventing and treating SARS-COV2, COVID-19, and coronavirus diseases and disorders, the risks of not getting vaccinated to prevent and treat SARS-COV2, COVID-19, and coronavirus diseases and disorders, the health risks of an under-immunized community, and equitable access to vaccines for preventing and treating SARS-COV2, COVID-19, and coronavirus diseases and disorders; educational services, namely, providing training and seminars in the field of vaccines and medicines for preventing and treating SARS-COV2, COVID-19, and coronavirus diseases and disorders; organizing and conducting educational meetings and conferences in the field of vaccines and medicines for preventing and treating SARS-COV2, COVID-19, and coronavirus diseases and disorders; Providing information on-line relating to educational instruction in the field of public health, the benefits of vaccines for preventing and treating SARS-COV2, COVID-19, and coronavirus diseases and disorders, the risks of not getting vaccinated to prevent and treat SARS-COV2, COVID-19, and coronavirus diseases and disorders, the health risks of an under-immunized community, and equitable access to vaccines for preventing and treating SARS-COV2, COVID-19, and coronavirus diseases and disorders | ACTIVE | Jun 4, 2020 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 10, 2024 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 10, 2024 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 28, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 28, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 28, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 15, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 15, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 15, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 5, 2023 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Sep 2, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Sep 2, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 2, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 2, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Sep 2, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 2, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 2, 2022 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Aug 25, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Aug 25, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Aug 25, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 22, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 22, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 22, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 22, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 22, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 22, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 14, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 12, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 17, 2021 | NWAP | NEW APPLICATION ENTERED | — |